High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : a retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples